# CapsoVision

其 CapsoCam Plus 胶囊内镜设备已获批用于儿科，该公司作为上市公司已公布2026年第一季度财务业绩。

Source: https://cn.bioecon.ru/companies/capsovision/
Updated: 2026-07-20

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | $1400万私募配售于2026年3月16日完成 | https://www.globenewswire.com/news-release/2026/03/20/3259701/0/en/CapsoVision-Announces-14-Million-Private-Placement-Financing.html, https://www.sec.gov/Archives/edgar/data/1378325/000137832526000019/cv-20260514xex991q12026ear.htm |
| 营收 | 2026年第二季度为$360万;2026年第一季度为$280万 | https://investors.capsovision.com/node/7531/pdf, https://www.biospace.com/press-releases/capsovision-reports-first-quarter-2026-financial-results, https://www.globenewswire.com/news-release/2026/05/14/3295350/0/en/CapsoVision-Reports-First-Quarter-2026-Financial-Results.html, https://www.sec.gov/Archives/edgar/data/1378325/000137832526000019/cv-20260514xex991q12026ear.htm |
| 监管批准 | 2025年1月9日宣布获 FDA 许可用于儿科（两岁及以上） | https://capsovision.com/capsocam-plus/, https://capsovision.com/news/, https://investors.capsovision.com/news-releases/news-release-details/capsovisions-capsocam-plusr-capsule-endoscopy-system-receives |
| 认证 | 2020年12月4日取得ISO 27001认证 | https://capsovision.com/news/ |
| 生产基地 | 组件主要来自亚洲，尤其是台湾和日本 [中等置信度] | https://www.sec.gov/Archives/edgar/data/1378325/000119312525116894/0001193125-25-116894.txt, https://www.sec.gov/Archives/edgar/data/1378325/000119312525149285/d916440ds1a.htm |

独立来源: biospace.com, globenewswire.com, sec.gov

## 技术

- [可摄入生物传感器 / 智能药丸](https://cn.bioecon.ru/technology/ingestible-biosensors-smart-pills/)